Lunai Bioworks
LNAI
29 hedge funds and large institutions have $6.43M invested in Lunai Bioworks in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 4 closing their positions.
21% more capital invested
Capital invested by funds: $5.31M → $6.43M (+$1.11M)
0% more funds holding
Funds holding: 29 → 29 (0)
0% less ownership
Funds ownership: 0.04% → 0.04% (-0%)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
+$241K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$184K |
| 3 |
BlackRock
New York
|
+$89.9K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$51.6K |
| 5 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
+$14.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$246K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$133K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$103K |
| 4 |
Goldman Sachs
New York
|
-$73K |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
-$63.9K |
LNAI Hedge Fund Activity: Q3 2019 in Review
29 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q3 2019, worth a combined $6.43M — up 21% from $5.31M a quarter earlier.
Fund positioning in LNAI was balanced in Q3 2019: 4 funds opened new positions, 4 closed out, 8 added to existing stakes and 9 trimmed.
The largest buyer was United Capital Financial Advisors, adding an estimated $241K. The largest seller was Millennium Management, cutting an estimated $246K.
- 29 institutional investors held Lunai Bioworks (LNAI) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $6.43M of Lunai Bioworks stock for Q3 2019, up 21% quarter-over-quarter.
- 4 funds opened new Lunai Bioworks positions in Q3 2019 and 4 closed out, a net change of 0 holders.
- The largest Lunai Bioworks buyer in Q3 2019 was United Capital Financial Advisors, an estimated $241K added.
- The largest Lunai Bioworks seller in Q3 2019 was Millennium Management, an estimated $246K sold.
Based on aggregated 13F filings for Q3 2019.